Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

Phage therapy is recognized as a promising alternative to antibiotics in treating pulmonary bacterial infections, however, its use has not been reported for treating secondary bacterial infections during virus pandemics such as coronavirus disease 2019 (COVID-19). We enrolled 4 patients hospitalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Nannan, Dai, Jia, Guo, Mingquan, Li, Jianhui, Zhou, Xin, Li, Feng, Gao, Yuan, Qu, Hongping, Lu, Hongzhou, Jin, Jing, Li, Tao, Shi, Lei, Wu, Qingguo, Tan, Ruoming, Zhu, Mingli, Yang, Lan, Ling, Yun, Xing, Shunpeng, Zhang, Jianzhong, Yao, Bangxin, Le, Shuai, Gu, Jingmin, Qin, Jinhong, Li, Jie, Cheng, Mengjun, Tan, Demeng, Li, Linlin, Zhang, Yiyuan, Zhu, Zhaoqin, Cai, Jinfeng, Song, Zhigang, Guo, Xiaokui, Chen, Li-Kuang, Zhu, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032346/
https://www.ncbi.nlm.nih.gov/pubmed/33703996
http://dx.doi.org/10.1080/22221751.2021.1902754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032346/
https://www.ncbi.nlm.nih.gov/pubmed/33703996
http://dx.doi.org/10.1080/22221751.2021.1902754

Ejemplares similares